Sacubitril/valsartan-A new weapon for fighting the hypertension paradox

Hypertens Res. 2022 May;45(5):915-916. doi: 10.1038/s41440-022-00872-w. Epub 2022 Mar 10.

Author

Mitsuru Ohishi¹

Affiliation

¹ Department of Cardiovascular Medicine and Hypertension, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan. ohishi@m2.kufm.kagoshima-u.ac.jp.

PMID: 35273352
DOI: 10.1038/s41440-022-00872-w

No abstract available

Publication types

Editorial

MeSH terms

Aminobutyrates / pharmacology
Aminobutyrates / therapeutic use
Biphenyl Compounds
Drug Combinations
Heart Failure* / drug therapy
Humans
Hypertension* / drug therapy
Tetrazoles / therapeutic use
Valsartan / therapeutic use

Substances

Aminobutyrates
Biphenyl Compounds
Drug Combinations
Tetrazoles
sacubitril
Valsartan